Ineffective health technology assessment (HTA) processes for high technology medicines and healthcare technologies in Peru
in PeruTrade barrier summary
Peru's HTA processes lack analytical robustness, transparency and predictability. This harms pharmaceutical exports by undermining the adoption of innovative and cost-effective UK drugs in the Peruvian health system.
Sectors affected
- Healthcare services
- Medical devices and equipment
Resolved
No
Date reported
18 January 2023
Last updated
17 December 2025
Public ID
PID-B75KPG
If a trade barrier is affecting your exports or investment from the UK, please let us know on report a trade barrier .
If you export goods you can check duties and customs procedures for your chosen market.